CW

Chaoling Wan

National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University

Affiliated withThe First Affiliated Hospital of Soochow University

Research Area

Biography

Chaoling Wan has not added Biography.
If you are Chaoling Wan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Canertinib as an FLT3 Inhibitor with Potent Activity Against FLT3-Mutated and AC220-Resistant Acute Myeloid Leukemia
Publication title
2025

Other Publications

Article
Year

Leukemia & lymphoma| PubMed ID: 34323656

2021

Frontiers in oncology| PubMed ID: 34540696

2021

Frontiers in oncology| PubMed ID: 34956909

2021

Clinical case reports| PubMed ID: 35140963

2022

Frontiers in oncology| PubMed ID: 35211416

2022

Annals of hematology| PubMed ID: 36394582

2023

Clinical case reports| PubMed ID: 36619491

2023

Medicine| PubMed ID: 37026960

2023

Annals of hematology| PubMed ID: 37103615

2023

Blood cancer journal| PubMed ID: 37137904

2023

Frontiers in immunology| PubMed ID: 37143650

2023

Annals of hematology| PubMed ID: 37227492

2023

British journal of haematology| PubMed ID: 37246158

2023

Clinical case reports| PubMed ID: 38084356

2023

Blood cancer journal| PubMed ID: 38238305

2024

Leukemia research| PubMed ID: 38493755

2024

Haematologica| PubMed ID: 38961741

2024

Blood cancer journal| PubMed ID: 39179571

2024

Bone marrow transplantation| PubMed ID: 39658655

2025

Annals of hematology| PubMed ID: 39668198

2024

Leukemia & lymphoma| PubMed ID: 41048093

2025

Clinical epigenetics| PubMed ID: 41084078

2025

Zhongguo shi yan xue ye xue za zhi| PubMed ID: 41234101

2025

The Lancet. Haematology| PubMed ID: 41338863

2025